Karen Bernstein
Director/Board Member chez OVID THERAPEUTICS INC.
Fortune : 61 000 $ au 31/03/2024
Profil
Karen Bernstein is the founder of BioCentury Publications, Inc. She currently holds the following positions: Independent Director at Ovid Therapeutics, Inc. since 2015, Independent Director at Codiak BioSciences, Inc. since 2019, Member-Overseers Board at The Scripps Research Institute since 2018, and Trustee at Keck Graduate Institute of Applied Life Sciences since 2009.
Previously, she served as an Independent Director at Achaogen, Inc. from 2017 to 2019 and as a Director at Vitae Pharmaceuticals LLC from 2015 to 2016.
Dr. Bernstein obtained a doctorate degree from Stanford University and an undergraduate degree from Brandeis University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OVID THERAPEUTICS INC.
0,03% | 22/02/2024 | 20 000 ( 0,03% ) | 61 000 $ | 31/03/2024 |
Postes actifs de Karen Bernstein
| Sociétés | Poste | Début |
|---|---|---|
| OVID THERAPEUTICS INC. | Director/Board Member | 30/09/2015 |
| CODIAK BIOSCIENCES | Director/Board Member | 01/02/2019 |
BioCentury Publications, Inc.
 BioCentury Publications, Inc. Publishing: Books/MagazinesConsumer Services BioCentury Publications, Inc. publishes a bioindustry news. It provides information, analysis and data for biotechnology and pharmaceutical companies, investors, academia, and government on the strategic issues essential to the formation, development and sustainability of life science ventures worldwide. The company was founded by David Flores and Karen Bernstein in 1992 and is headquartered in Redwood City, CA. | Founder | - |
| Keck Graduate Institute of Applied Life Sciences | Director/Board Member | 01/09/2009 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | 01/10/2018 |
Anciens postes connus de Karen Bernstein
| Sociétés | Poste | Fin |
|---|---|---|
| ACHAOGEN | Director/Board Member | 23/07/2019 |
| VITAE PHARMACEUTICALS INC | Director/Board Member | 25/10/2016 |
Formation de Karen Bernstein
| Stanford University | Doctorate Degree |
| Brandeis University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OVID THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
BioCentury Publications, Inc.
BioCentury Publications, Inc. Publishing: Books/MagazinesConsumer Services BioCentury Publications, Inc. publishes a bioindustry news. It provides information, analysis and data for biotechnology and pharmaceutical companies, investors, academia, and government on the strategic issues essential to the formation, development and sustainability of life science ventures worldwide. The company was founded by David Flores and Karen Bernstein in 1992 and is headquartered in Redwood City, CA. | Consumer Services |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |
